Vaccine stocks gain amid uptick in flu, COVID-19, RSV

Shares of vaccine makers moved higher early Monday following a CDC report that the U.S. was seeing a significant uptick in acute respiratory illness due to higher rates of seasonal influenza, COVID-19 and RSV.

“The amount of acute respiratory illness